The tweet was deleted by the author.
But we saved everything 🙂.
CME Group says traders are turning to E-mini S&P 500 futures and Adjusted Interest Rate Total Return futures. The company points to these products as tools for navigating balance sheet scarcity and maximizing capital efficiency.
CME Group refers readers to its latest article for more information. Details are included in the linked article.
View post on X Loading...
CME Group ($265.44) is trading firmly above its MA-20 ($245.68) and MA-50 ($254.27), but remains below its MA-200 ($278.60). This configuration signals strong short- and medium-term bullish momentum, yet longer-term trend pressure persists from above; the Ichimoku Kijun at $242.22 now acts as immediate support. Near-term support sits at the MA-50 ($254.27) and Ichimoku Kijun ($242.22). Key support is found at the MA-100 ($275.75). Immediate resistance is the MA-200 ($278.60), with a secondary cap around the MA-100 ($275.75).
Momentum indicators on D1 are robust: MACD and ADX both confirm a bullish trend, while RSI (65.33) points to continued buyer strength. However, CCI (191.28), Stoch RSI (100.00), and BBP (14.63) all flag overbought conditions, indicating elevated risk of a pullback despite persistent buyer dominance. The Awesome Oscillator supports the upward trend as well. CME has advanced $10.13 (3.97%) over the past week, rising from a prev_week_close of $255.31, with volatility at 6.56%. The price currently stands at the very top of the weekly range, suggesting potential resistance as the market is testing the highs. In today's session, CME gained 2.09%, highlighting aggressive intraday buying. The weekly tone is marked by a strong push from midrange to the upper end of the band.
For the upcoming week, the expected range is $255.00–$272.00, keeping price movement well within 20% of the current level and anchored far above the 52-week low ($218.31) but below the 52-week high ($329.16). Based on W1 indicators—where MA-100 points to a potential buy but W1 RSI and MACD remain bearish—there is a very low probability (less than 20%) of a further sustained price increase. Downside risk is thus more likely. The baseline scenario sees CME consolidating between $255.00 and $272.00. A bullish breakout above $272.00 could target the MA-200 area, while a bearish scenario would see the price breaking below $255.00 and potentially retracing towards the mid-$240s.
Previously it was reported that CME Group's shares demonstrated bullish momentum but faced strong long-term resistance, prompting expectations for a period of consolidation. In light of recent developments, traders should now focus on shifts in liquidity and emerging volatility signals as potential catalysts for a breakout or renewed pullback in the stock.